Abstract:Objective: Hepcidin deficiency is known to cause body iron accumulation and bone microarchitecture defects, but the exact underlying mechanisms of hepcidin deficiency-induced bone loss remain unclear. Our objective was to understand the molecular mechanism of hepcidin deficiency-induced bone loss. Methods: The bone phenotypes of wild type (WT) and hepcidin knockout (Hepcidin-KO) mice were measured by microcomputed tomography. The osteoclastic marker of the bone was measured by tartrate-resistant acid phosphatase staining. The osteoblastic marker of the bone was measured by immunostaining of osteocalcin. Primary osteoblastic and osteoclastic differentiation was performed using bone marrow cells. The mature osteoclast was determined by tartrate-resistant acid phosphatase staining, pit formation assay and relative gene expression. The mature osteoblast was determined by alkaline phosphatase activity, alkaline phosphatase staining, Alizarin Red staining and relative gene expression. The protein expression of beta-catenin, TCF4/TCF7L2 and Forkhead box O3a (FOXO3a) was measured by Western blot and their combination by co-immunoprecipitation. In vivo study was performed by tail vein administration of FOXO3a-RNAi using an adeno-associated virus in Hepcidin-KO mice. Results: We found that Hepcidin-KO mice exhibited iron accumulation and bone loss compared with WT mice. The osteoclastic differentiation of bone marrow-derived macrophages from Hepcidin-KO mice was not significantly different from that of bone marrow -derived macrophages from WT mice. However, the osteoblastic differentiation of bone marrow -derived mesenchymal stem cells from Hepcidin-KO mice was obviously decreased compared with that of bone marrow -derived mesenchymal stem cells from WT mice. Furthermore, it was confirmed in this study that upon hepcidin deficiency, beta-catenin, TCF4/TCF7L2 and FOXO3a expression in bone tissues was not altered, but beta-catenin combination with TCF4/TCF7L2 was strongly inhibited by beta-catenin combination with FOXO3a, indicating that the canonical Wnt/beta-catenin pathway was affected. Tail vein administration of FOXO3a-RNAi using an adeno-associated virus in Hepcidin-KO mice resulted in bone mass recovery. Conclusion: These findings suggested that hepcidin deficiency might cause bone loss by interfering with the canonical Wnt/beta-catenin pathway via FOXO3a, and FOXO3a inhibition would be a possible approach to treat hepcidin deficiency-induced bone loss. The translational potential of this article: Hepcidin deficiency, as well as iron accumulation, has been considered as a risk factor for osteoporosis. For this kind of osteoporosis, inhibition of FOXO3a either by neutralized antibody or AAV-mediated RNAi, represents an effective and promising method.

Hepcidin contributes to Swedish mutant APP-induced osteoclastogenesis and trabecular bone loss

Osteoblastic Swedish mutant APP expedites brain deficits by inducing endoplasmic reticulum stress-driven senescence

Astrocyte Hepcidin Ameliorates Neuronal Loss Through Attenuating Brain Iron Deposition and Oxidative Stress in APP/PS1 Mice.

The Role of Copper and the Copper-Related Protein CUTA in Mediating APP Processing and Aβ Generation

Aβ ‐induced excessive mitochondrial fission drives type H blood vessels injury to aggravate bone loss in APP/PS1 mice with Alzheimer's diseases

Copper Levels Are Increased in the Cerebral Cortex and Liver of APP and APLP2 Knockout Mice

Effects of mouse hepcidin 1 treatment on osteoclast differentiation and intracellular iron concentration

Hepcidin Deficiency Causes Bone Loss Through Interfering with the Canonical Wnt/β-catenin Pathway Via Forkhead Box O3a

Hepcidin Overexpression in Astrocytes Alters Brain Iron Metabolism and Protects Against Amyloid-Β Induced Brain Damage in Mice

Osteoclasts Link Dysregulated Peripheral Degradation Processes and Accelerated Progression in Alzheimer's Disease

β-Amyloid peptide increases levels of iron content and oxidative stress in human cell and Caenorhabditis elegans models of Alzheimer disease.

Orexin-A Aggravates Cytotoxicity and Mitochondrial Impairment in SH-SY5Y Cells Transfected with APPswe Via P38 MAPK Pathway

Iron accumulation induced by hepcidin1 knockout accelerates the progression of aging osteoporosis

Apolipoprotein D Modulates Amyloid Pathology in APP/PS1 Alzheimer's Disease Mice

High Dietary Iron Disrupts Iron Homeostasis And Induces Amyloid-Beta And Phospho-Tau Expression In The Hippocampus Of Adult Wild-Type And App/Ps1 Transgenic Mice

Hepcidin deficiency impairs hippocampal neurogenesis and mediates brain atrophy and memory decline in mice

Marked Age-Related Changes in Brain Iron Homeostasis in Amyloid Protein Precursor Knockout Mice

Iron Exposure and the Cellular Mechanisms Linked to Neuron Degeneration in Adult Mice

Apolipoprotein E deficiency induces a progressive increase in tissue iron contents with age in mice

The Alzheimer's Disease Amyloid Precursor Protein Modulates Copper-Induced Toxicity and Oxidative Stress in Primary Neuronal Cultures.

Exposure to Metal Ions Regulates Mrna Levels of APP and BACE1 in PC12 Cells: Blockage by Curcumin